Insulin Glulisine
Insulin Glulisine , also known as Apidra, is a fast-acting, mealtime insulin injection containing human insulin created by recombinant DNA technology. It is used to treat Type 1 and Type 2 diabetes in adults and children.
Uses For
Insulin Glulisine is used to lower blood sugar levels in patients with type 1 or 2 diabetes. It is used when a patient's body does not produce enough insulin, or when the insulin that the body produces is not working properly. It is injected under the skin and acts quickly to lower blood sugar levels after meals. It is also used to help reduce the risk of complications from diabetes, such as kidney, eye, and nerve damage.
| Brand Name | Insulin Glulisine |
|---|---|
| Type | |
| Weight | |
| Generic | Insulin Glulisine |
| Manufacturer | |
| Available in | English বাংলা |
Mechanism of Action
Insulin Glulisine works by increasing the amount of glucose taken in from the bloodstream and making it available to the cells for energy. Insulin Glulisine also decreases the production of glucose (sugar) by the liver, which helps to reduce high blood glucose levels. Insulin Glulisine helps the body convert sugar, starches, and other food into energy that the cells need.
How Long Does It Take to Work?
Insulin Glulisine takes approximately 10-15 minutes to reach peak glucose-lowering activity and typically lasts up to 4 hours. Insulin Glulisine should be taken with meals, and it is important for patients to follow their prescribed dosing schedule.
Absorption
Insulin Glulisine is rapidly absorbed under the skin and reaches peak activity in 10-15 minutes. It is best to take the injection before meals, and the dose may need to be altered if the patient's meal sizes or content changes.
Route of Elimination
Insulin Glulisine is broken down in the body by enzymes, and it is mainly eliminated through the urine.
Dosage
Individualize and adjust the dosage of insulin glulisine based on the route of administration, individual's metabolic needs, blood glucose monitoring results, and glycemic control goal.Dosage adjustments may be needed when switching from another insulin, with changes in physical activity, changes in concomitant medications, changes in meal patterns, changes in renal or hepatic function or during acute illness.
Subcutaneous Injection:
- Inject within 15 minutes before a meal or within 20 minutes after starting a meal into the abdomen, thigh, or upper arm.
- Rotate injection sites within the same region to reduce the risk of lipodystrophy and localized cutaneous amyloidosis.
- Should generally be used in regimens with intermediate or long-acting insulin.
- Administer by continuous subcutaneous infusion using an insulin pump in a region recommended in the instructions from the pump manufacturer.
- Rotate infusion sites within the same region to reduce the risk of lipodystrophy and localized cutaneous amyloidosis.
- Do not dilute or mix insulins in external insulin pumps.
The dose of Insulin Glulisine will vary for each patient depending on blood sugar levels, meal intakes, body weight, and other individual factors. The patient's doctor will determine the appropriate dose. Insulin Glulisine is usually injected under the skin of the upper arm, thigh, buttocks, or abdomen, and is usually taken with meals.
Administration
Insulin Glulisine is usually injected subcutaneously (under the skin) with an insulin pen or syringe. It is important to always use a clean and sterile needle or syringe for each injection. Patients should not inject Insulin Glulisine in the same spot each time; rotating injection sites can help reduce localized skin irritation.
Side Effects
Common side effects of Insulin Glulisine include localized skin irritation, low blood sugar levels, weight gain, nausea, vomiting, and fatigue. In some rare cases, patients have experienced allergic reactions to the medication, including hives, difficulty breathing, and swelling. It is important to contact your healthcare provider immediately if you experience any of the above side effects.
Toxicity
If too much Insulin Glulisine is taken, it can lead to severe hypoglycemia or low blood sugar levels. Symptoms of hypoglycemia include dizziness, confusion, sweating, difficulty concentrating, rapid heartbeat, and hunger. If you experience any of these symptoms, contact your healthcare provider immediately and consume a source of sugar.
Precautions
Insulin Glulisine should be taken with food and should not be taken if a patient has low blood sugar levels. It is important to tell your doctor about any allergies you may have and to let them know if you are pregnant, trying to become pregnant, or breastfeeding. It is also important to tell your doctor if you are taking any other medications, including herbal supplements, as Insulin Glulisine may interact with certain medications.
Interactions
Insulin Glulisine may interact with medications, foods, and supplements. It is important to tell your doctor about any medications, foods, or supplements that you are taking in order to avoid any potential interactions. Some medications that may interact with Insulin Glulisine include sulfonylurea, antibiotics, heavy alcohol consumption, and certain diuretics.
Disease Interaction
If you have a medical condition such as kidney disease, thyroid disease, or diabetes, it is important to talk to your doctor about any potential interactions with Insulin Glulisine . Certain conditions such as thyroid disease may affect the way Insulin Glulisine works, so it is important to be aware of any potential interactions or side effects.
Drug Interaction
Certain medications such as sulfonylurea, antibiotics, heavy alcohol consumption, and certain diuretics may interact with Insulin Glulisine . It is important to talk to your doctor about any potential drug interactions before taking this medication.
Food Interactions
Insulin Glulisine may interact with certain foods and drinks, so it is important to be aware of any potential interactions or side effects. Foods that may interact with Insulin Glulisine include high-fat foods, sweets, and alcohol.
Pregnancy Use
Women who are pregnant or nursing should talk to their doctor about any potential interactions with Insulin Glulisine before taking this medication. It is not known whether Insulin Glulisine is safe and effective for use in pregnant women, so it is important to talk to your doctor before taking this medication.
Lactation Use
Women who are nursing should talk to their doctor about any potential interactions with Insulin Glulisine before taking this medication. It is not known whether Insulin Glulisine is safe and effective for use in lactating women, so it is important to talk to your doctor before taking this medication.
Acute Overdose
If an overdose of Insulin Glulisine is taken, it is important to seek medical attention immediately. Overdoses of Insulin Glulisine can result in low blood sugar levels, which can lead to seizures, loss of consciousness, coma, and even death.
Contraindication
Insulin Glulisine should not be used if you have a known allergy or reaction to insulin glulisine or any of its ingredients or if you have low blood sugar levels. It is also not advised for use in pregnant women or women who are nursing.
Use Direction
Insulin Glulisine should be taken as directed by your doctor. The dosage and frequency of administration should be based on individual glucose and patient-specific needs. The typical starting dose of Insulin Glulisine is 0.5 units/kg. When changing from another insulin to Insulin Glulisine , your doctor may adjust the dose as needed. Insulin Glulisine should be taken before meals, and it is important to follow your doctor’s instructions for dosing.
Storage Condition
Insulin Glulisine should be stored in a cool, dark place, away from direct sunlight and heat. Insulin should not be stored in the refrigerator. Once opened, Insulin Glulisine should be used within 28 days and should not be frozen or shaken.
Volume of Distribution
The volume of distribution of Insulin Glulisine is 1.6-2.7 L/kg. This means that the average amount of insulin in the body at any given time is 1.6-2.7 liters per kilogram of body weight.
Half life
The half-life of Insulin Glulisine is approximately 2.4 hours. This means that after 2.4 hours, the amount of insulin in the body will have decreased by approximately 50%. It is important to monitor blood sugar levels closely if taking Insulin Glulisine .
Clearance
The clearance of Insulin Glulisine is about 0.25 L/hr/kg. This means that the amount of insulin is removed from the body at a rate of 0.25 liters per hour for each kilogram of body weight.
See in details version Insulin Glulisine also Insulin Glulisine in bangla
